Tenderwize
Back to tender search

Open-House Biologics Discount Agreements 2025-25 - Aflibercept

Techniker Krankenkasse·Hamburg, Germany·Deadline Nov 29, 2026 · 103 days left·Open·Supplies
Sign up to saveOpen documents
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-25 - Aflibercept (ATC: S01LA05; Wirkstärke: 40 mg/ml)

40/100

Opportunity Score

PromisingLow complexity
SuppliesOpen
Why this score?

Opportunity

40 / 100

Complexity

20 / 100

Risk factors

No estimated contract value or framework maximum is provided, making it difficult to assess business potential.

Structured data marks the tender as EU-funded, but the XML notice states 'no-eu-funds'. This may affect any EU funding...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Strong opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Nov 2026
  • Supply of Aflibercept (40 mg/ml) pharmaceutical products to TK's insured persons under discount agreements.
  • Contract duration up to 12 months starting 01 December 2025, ending 30 November 2026.
Show full summary

This is an Open-House procedure by Techniker Krankenkasse (TK) for discount agreements on the drug Aflibercept (ATC S01LA05, 40 mg/ml). The procedure is not a public procurement under EU directives; contracts are concluded with any qualified pharmaceutical entrepreneur on standardized terms. No estimated value, award criteria, or detailed procurement documents were analyzed. The deadline for submissions is 29 November 2026, but the procedure runs until 30 November 2026.

Risks

No estimated contract value or framework maximum is provided, making it difficult to assess business potential.

Structured data marks the tender as EU-funded, but the XML notice states 'no-eu-funds'. This may affect any EU funding...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical entrepreneur as per §4(18) AMG.
  • Must have a valid marketing authorization for the product or be otherwise entitled to market it.

Administrative

  • Must provide a self-declaration on authorization and reliability.

Requirements may be incomplete.

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open-House Biologics Discount Agreements 2025-25 - Aflibercept

Conclusion of pharmaceutical discount agreements under §130a Abs. 8 SGB V for the active substance Aflibercept (ATC S01LA05, 40 mg/ml) via an open-house procedure. No exclusivity; uniform conditions apply.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Nov 2025 - Nov 2026

Category

Pharmaceutical products

Deadline

Deadline Nov 29, 2026

Procurement Details

Publication date
04 Jun 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
386710-2026

Documents (1)

Procurement document 1

Similar tenders

Germany – Site preparation work – VE111 Baustelleneinrichtung (119VM514 / Kronsh,SanDstBw,Ersatzneub. ZInstSanBw)

Sep 15
1 SME lot

Poland – Advertising and marketing services – Zaplanowanie i realizacja kampanii Ministerstwa Finansów z zakresu działalności resortu finansów

Sep 17

France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord

Sep 14
6 SME lots

Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)

Aug 27
3 framework lots3 SME lots

Greece – Cultural event organisation services – ΛΕΙΤΟΥΡΓΙΑ ΤΟΥ ΘΕΑΤΡΟΥ ΟΛΥΜΠΙΑ ΜΑΡΙΑ ΚΑΛΛΑΣ ΜΕ ΕΞΕΙΔΙΚΕΥΜΕΝΟ ΠΡΟΣΩΠΙΚΟ

Sep 18

Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).

Sep 24